BioSpace News Archive

Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter 2019

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, February 14, 2020 to discuss its 2019 operating results.

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today announced the appointment of Lance Berry to its Board of Directors, and as a member and chair of the Audit Committee, both effective on January 29, 2020

Concert Pharmaceuticals, Inc. announced the closing of its previously announced underwritten public offering of 5,735,283 shares of its common stock to the public at $9.92 per share, which included the full exercise of the underwriters’ option to purchase 982,863 additional shares of common stock.

Gilead Sciences, Inc. announced that Sandra Horning, MD, has been appointed to the company’s Board of Directors.

Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its updated 3D VSHARP software for industrial cone beam computed tomography (CBCT) at iCT2020.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the full year and fourth quarter ended December 31, 2019 and provided full-year 2020 financial guidance.

Intec Pharma Ltd. announced that it intends to offer and sell a combination of ordinary shares and warrants to purchase ordinary shares in an underwritten public offering.

Healthpeak Properties, Inc. (NYSE: PEAK) announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, reported financial results for the quarter ended December 31, 2019.